About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Washington | 675 Studies

Clinical Trials Prostate CancerWashington

Prostate Cancer Clinical Trials in Washington

Find 675 clinical trials for prostate cancer near Washington. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Washington

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 81-100 of 675 trials

CompletedCardiovascular Risk and Preventive Care in Prostate Cancer Patients Receiving Radiation and Hormone TherapyThis study will evaluate the proportion of prostate cancer patients receiving external beam radiation therapy (EBRT) and androgen deprivation therapy (ADT) with controlled blood…NCT02003417·Washington D.C., District of Columbia and 7 others CompletedGenetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyThis trial studies the genetic analysis of blood and tissue samples from patients with cancer that has spread to other anatomic sites (advanced) or is no longer responding to…NCT03707574·Fort Lauderdale, Florida and 143 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

Active not recruitingA Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K MutationsThis is a Phase 1, open-label study to evaluate the safety and tolerability of ATV-1601 administered orally in adults with AKT1 E17K-mutant, advanced solid tumors and also in…NCT07038369·Los Angeles, California and 7 others

CompletedA Phase 1 Study of MDV3100 in Patients With Castration-Resistant (Hormone-Refractory) Prostate CancerThis is a multi-center open-label dose-escalation study of a novel compound (MDV3100) to treat patients with castration-resistant (hormone-refractory) prostate cancer.NCT00510718·Boston, Massachusetts and 8 others

CompletedComparison Study of MDX-010 (CTLA-4) Alone and Combined With Docetaxel in the Treatment of Patients With Hormone Refractory Prostate CancerThe primary objectives of the study are to determine the safety and activity of multiple doses of MDX-010 in patients with hormone-refractory prostate cancer (HRPC), and to…NCT00050596·Tucson, Arizona and 10 others

Active not recruitingTesting the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate CancerThis phase II trial tests how well M1774 works in treating patients with prostate cancer that does not respond to treatment (refractory) and that has a mutation in the gene…NCT05828082·Phoenix, Arizona and 25 others

WithdrawnA Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate CancerThis is a phase 1b study that follows a 3+3 dose escalation design and consists of a 21-day lead-in period of oral Polysaccharide Krestin (PSK)/placebo (study drug) alone followed…NCT01685489·Seattle, Washington

CompletedGabapentin in Treating Hot Flashes in Patients With Prostate CancerRATIONALE: Gabapentin may be effective in relieving hot flashes in men who have prostate cancer.NCT00028574·Mobile, Alabama and 169 others

CompletedStudy With IMC-A12 (Cixutumumab) in Patients Who Have Not Previously Been Treated With Chemotherapy With Metastatic Prostate CancerThis single arm, multicenter, open-label, Phase II study will enroll chemotherapy-naive participants with metastatic, histologically-confirmed adenocarcinoma of the prostate…NCT00520481·San Francisco, California and 2 others

CompletedABI-008 Trial in Patients With Hormone-refractory Prostate CancerTo determine the maximum tolerated dose (MTD) and dose-limiting toxicities (DLTs) of ABI-008 given every 3 weeks; to characterize the toxicities of ABI-008; and to determine the…NCT00477529·Ann Arbor, Michigan and 3 others

Active not recruitingA Study of Salvage Radiotherapy With or Without Enzalutamide in Recurrent Prostate Cancer Following SurgeryPatients with post-prostatectomy PSA (Prostate Specific Antigen) recurrences with aggressive disease features will receive salvage radiation therapy and standard androgen…NCT03809000·Gilbert, Arizona and 107 others

CompletedRadiation and Androgen Ablation for Prostate CancerA study to see how effective and tolerable radiation therapy along with androgen deprivation therapy is in treating prostate cancer.NCT01517451·Washington D.C., District of Columbia and 2 others

CompletedA Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate CancerThis is a Phase I, multicenter, open-label, dose-escalation study of DSTP3086S administered as a single agent by intravenous (IV) infusion to patients with metastatic…NCT01283373·San Francisco, California and 4 others

CompletedDegarelix Acetate Before and During Radiation Therapy in Treating Patients With Prostate CancerThis pilot clinical trial studies how well degarelix acetate before and during radiation therapy works in treating patients with prostate cancer.NCT01731912·Seattle, Washington

CompletedStudy Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer.This is a randomized, double-blind, multicenter, phase 3 study evaluating orteronel plus prednisone compared with placebo plus prednisone in men with metastatic…NCT01193257·Anchorage, Alaska and 77 others

CompletedProstate Cancer Screening: Fostering Informed DecisionsThe primary goal of this study is to develop and evaluate a print-based method of patient education with a decision tool that is designed to provide detailed information about…NCT00196807·Washington D.C., District of Columbia and 1 other

AvailableSingle Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate CancerDue to the subject's lack of conventional treatment options, a treatment plan using X-PACT administered intra-tumorally is proposed.NCT06836648·Washington D.C., District of Columbia

CompletedStudy of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial CancerThe primary objective in Phase I is to evaluate the safety and tolerability of sacituzumab govitecan-hziy (SG) as a single agent administered in 21-day treatment cycles in…NCT01631552·Aurora, Colorado and 11 others

CompletedIbrutinib as Neoadjuvant Therapy in Localized Prostate Cancer30-40% of patients who undergo radical prostatetecomy (RP) with curative intent for their localized prostate cancer experience relapse of their disease.NCT02643667·San Francisco, California and 1 other

CompletedA Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate CancerEnthuse M1C is a large phase III clinical trial studying the safety and efficacy of ZD4054 (Zibotentan) in combination with docetaxel (Taxotere) in patients with metastatic…NCT00617669·Greenbrae, California and 146 others

PreviousPage 5 of 34Next

Other Conditions in Washington

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma